mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
Mdivi-1 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.7 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |